Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike to ...

CRISPR, the gene-editing technology which won its creators the 2020 Nobel Prize for Chemistry, is most well-known for its ...

In a shift away from GMOS, aka genetically modified organisms, important research is continuing in gene editing, sometimes referred to as “the next big thing in agriculture.” The important difference ...

One such innovation is now being trialled in Spain by Corteva, a global agricultural technology company. Corteva’s ...

Volatile macroeconomic events are magnified in life science and healthcare applications, which are capital intensive, long-term investments with associated regulatory, safety, and commercial risks.

Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

The gene editing technologies market is driven by technological advancements enhancing precision, expanding applications in personalized medicine, and rising genetic disorder prevalence. Despite ...